Takeda (TAK) and Vela Transport announced their business partnership, with Takeda set to become the first biopharmaceutical company to transport its products between Europe and the U.S. using Vela’s sailing cargo trimaran. Vela designed and will operate a fleet of new generation sailing cargo vessels, powered 100% by wind when at sea.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TAK:
- Protagonist Therapeutics initiated with an Outperform at Leerink
- Alkermes price target lowered to $43 from $45 at Needham
- Harmony Biosciences price target lowered to $48 from $49 at Needham
- Alkermes price target raised to $35 from $34 at JPMorgan
- Promising Phase 3 Results for Takeda’s Oveporexton Boost Buy Rating